Detalles de la búsqueda
1.
Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21252340
2.
Safety of administering biologics to IBD patients at an outpatient infusion center In New York City during the COVID-19 pandemic: Sars-CoV-2 seroprevalence and clinical and social characteristics
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21253615
3.
SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20151126
4.
Neutralizing Antibody Responses in COVID-19 Convalescent Sera
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20150557
5.
An inflammatory cytokine signature helps predict COVID-19 severity and death
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20115758
6.
Convalescent plasma treatment of severe COVID-19: A matched control study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20102236
7.
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22271399
Resultados
1 -
7
de 7
1
Próxima >
>>